The Readout Loud

Episodes

• 340: Crisis in CRISPR world, RFK Jr.'s promises, and a novel non-opioid pain drug

  Feb 6, 2025

  Not summarized yet

• 339: RFK Jr.'s confirmation hearings, MASH drugs, and a controversial obesity ad

  Jan 30, 2025

  Not summarized yet

• 338: Chinese biotechs, a WHO departure, and post-JPM thoughts

  Jan 23, 2025

  Not summarized yet

• 337: Eli Lilly CEO on Trump, obesity drugs, and a guidance miss

  Jan 15, 2025

  Not summarized yet

• 336: Pharma's big patent cliff, more obesity fundraising, and a failed ALS study

  Jan 9, 2025

  Not summarized yet

• 335: A deep dive on Makary, Vertex's pain data, & 2025 predictions

  Dec 19, 2024

  Not summarized yet

• 334: Pharma silence on RFK Jr. & parents trying to develop gene therapies for their children

  Dec 12, 2024

  Not summarized yet

• 333: An H5N1 bird flu update and talent scarcity in the radiopharma field

  Dec 5, 2024

  Not summarized yet

• 332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?

  Nov 21, 2024

  Not summarized yet

• 331: AbbVie’s stumble, Amgen’s tumble and more election fallout

  Nov 14, 2024

  Not summarized yet

• 330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks

  Nov 7, 2024

  Not summarized yet

• 329: Lilly's earnings surprise, investors mull the election, & a spooky ghost story

  Oct 31, 2024

  Not summarized yet

• 328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions

  Oct 24, 2024

  Not summarized yet

• 327: Biotech's next gold rush, GLP-1 shortages, and STAT Summit highlights

  Oct 17, 2024

  Not summarized yet

• 326: Crypto for CRISPR, a new RNAi startup, & a Nobel for AI

  Oct 10, 2024

  Not summarized yet

• 325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO

  Oct 3, 2024

  Not summarized yet

• From Tradeoffs: Race to the Bottom

  Sep 28, 2024

  Not summarized yet

• 324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug

  Sep 26, 2024

  Not summarized yet

• 323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

  Sep 19, 2024

  Not summarized yet

• 322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids

  Sep 12, 2024

  Not summarized yet